Use of melatonin to prevent cytotoxic effects of amyloid beta protein
First Claim
Patent Images
1. A method of enhancing the survivability of cells that have been subjected to cytotoxic effects of amyloid beta protein comprising exposing said cells to an effective amount of melatonin.
6 Assignments
0 Petitions
Accused Products
Abstract
The present invention is directed to a method of preventing cytotoxic effects of amyloid beta protein on cells. The method comprises exposing the cells to an effective amount of melatonin. The invention further provides a method of treating Alzheimer'"'"'s disease in a human subject, which comprises administering an amount of melatonin effective to prevent the cytotoxic effects of amyloid beta protein to the human subject.
20 Citations
13 Claims
- 1. A method of enhancing the survivability of cells that have been subjected to cytotoxic effects of amyloid beta protein comprising exposing said cells to an effective amount of melatonin.
- 11. A method of enhancing the survivability of cells that have been subjected to cytotoxic effects of amyloid beta protein in a patient afflicted with Alzheimer'"'"'s disease, comprising administering melatonin to the patient in an amount effective to alleviate symptoms associated with said disease.
Specification